prademagene zamikeracel 41.3 SQCM Medicated Patch

RxCUI: 2713347
RxNorm name: prademagene zamikeracel 41.3 SQCM Medicated Patch
Display name: prademagene zamikeracel 41.3 SQCM Medicated Patch
Full name: prademagene zamikeracel 41.3 SQCM Medicated Patch
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:28

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125807	zevaskyn	Prademagene zamikeracel	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ZEVASKYN	PRADEMAGENE ZAMIKERACEL	Abeona Therapeutics Inc.	f8782480-8782-4748-9764-b9ed60979d47	2026-03-19	Warnings, Adverse reactions	Exact identifier rxcui: 2713347

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
f8782480-8782-4748-9764-b9ed60979d47	prademagene zamikeracel 41.3 SQCM Medicated Patch	SCD	6	These highlights do not include all the information needed to use ZEVASKYN ® safely and effectively. See full prescribing information for ZEVASKYN . ZEVASKYN ( prademagene zamikeracel ) , gene - modified cellular sheet s , for topical use Initial U.S. Approval: 20 25	20260331
f8782480-8782-4748-9764-b9ed60979d47	prademagene zamikeracel 41.25 SQCM Cellular Sheet	PSN	6	These highlights do not include all the information needed to use ZEVASKYN ® safely and effectively. See full prescribing information for ZEVASKYN . ZEVASKYN ( prademagene zamikeracel ) , gene - modified cellular sheet s , for topical use Initial U.S. Approval: 20 25	20260331
f8782480-8782-4748-9764-b9ed60979d47	prademagene zamikeracel 41.25 SQCM Cellular Sheet	SY	6	These highlights do not include all the information needed to use ZEVASKYN ® safely and effectively. See full prescribing information for ZEVASKYN . ZEVASKYN ( prademagene zamikeracel ) , gene - modified cellular sheet s , for topical use Initial U.S. Approval: 20 25	20260331